tiprankstipranks
Advertisement

PQNT - ETF AI Analysis

Compare

Top Page

PQNT

Pictet AI Enhanced International Equity ETF (PQNT)

Rating:67Neutral
Price Target:
PQNT, the Pictet AI Enhanced International Equity ETF, has a solid overall rating driven mainly by high-quality global leaders like ASML and major pharmaceutical names such as AstraZeneca and Novartis, which show strong financial performance, healthy growth prospects, and generally positive technical trends. Financial institutions like BBVA and ABN AMRO also support the rating with good revenue growth and reasonable valuations, though issues such as high leverage, overvaluation risks, and operational or cash flow challenges at holdings like ING Groep and Siemens Energy introduce some caution. The main risk factor is the fund’s notable exposure to financial and healthcare names, where valuation concerns and potential overbought conditions could increase volatility.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the last few months, showing positive momentum.
Global Diversification
Holdings spread across many countries, including Japan, the UK, Europe, and others, help reduce reliance on any single market.
AI-Selected International Leaders
Several top positions, such as ASML and other financial and industrial names, have shown strong performance, suggesting the AI-driven stock selection has added value.
Negative Factors
Small Fund Size
With relatively low assets under management, the ETF may be less liquid and more vulnerable to large investor inflows or outflows.
Mixed Top Holding Performance
Some major positions, including AstraZeneca, Roche, and Sony, have been weak this year, which can drag on overall returns.
Moderate Expense Ratio
The fund’s fee is not especially high but is also not among the cheapest, which slightly reduces net returns over time.

PQNT vs. SPDR S&P 500 ETF (SPY)

PQNT Summary

Pictet AI Enhanced International Equity ETF (PQNT) is an actively managed fund that uses artificial intelligence to pick stocks from developed markets outside North America. It doesn’t track a fixed index, but instead aims to find strong large- and mid-sized companies across many sectors, including financials, health care, and technology. Well-known holdings include ASML and Sony. Someone might invest in PQNT for diversified international stock exposure with an AI-driven stock selection approach that seeks growth. A key risk is that its share price can rise or fall with global stock markets, and its AI strategy may not always outperform.
How much will it cost me?The Pictet AI Enhanced International Equity ETF (PQNT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average because it is actively managed, using advanced AI technology to select investments rather than following a passive index. Active management typically involves more research and strategy, which increases costs.
What would affect this ETF?The Pictet AI Enhanced International Equity ETF (PQNT) could benefit from advancements in artificial intelligence and strong performance in developed markets outside North America, particularly in sectors like Financials, Industrials, and Technology, which make up a significant portion of its holdings. However, it may face challenges from global economic slowdowns, regulatory changes in international markets, or sector-specific risks, such as volatility in the Financial sector or slower growth in Technology. Additionally, currency fluctuations and geopolitical tensions in developed markets could negatively impact returns.

PQNT Top 10 Holdings

PQNT leans heavily into developed markets outside North America, with Europe doing much of the heavy lifting. ASML is the clear engine here, rising on strong demand for chipmaking gear and giving the fund a tech-powered boost. Financials are another key storyline: ABN AMRO, ING, and BBVA have been climbing, helping steady overall returns. On the flip side, big pharma names like AstraZeneca and Roche are losing steam, and Sony’s mixed performance isn’t helping. Overall, the fund is diversified but with a noticeable tilt toward European banks and health care giants.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.79%$424.41K€633.25B151.49%
76
Outperform
AstraZeneca2.07%$232.08K$271.40B27.54%
80
Outperform
Roche Holding AG1.38%$154.91K$315.55B23.56%
73
Outperform
Novartis AG1.37%$153.90KCHF215.97B26.50%
80
Outperform
British American Tobacco1.25%$140.72K£93.69B23.50%
71
Outperform
Banco Bilbao Vizcaya Argentaria1.20%$135.05K€119.92B72.00%
76
Outperform
Siemens Energy1.11%$124.88K€143.91B95.75%
72
Outperform
ABN AMRO Group N.V.1.11%$124.70K€31.10B65.49%
74
Outperform
ING GROEP1.08%$121.02K€79.26B55.66%
61
Neutral
Sony1.07%$119.88K¥18.61T-19.39%
73
Outperform

PQNT Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
22.38
Positive
100DMA
22.08
Positive
200DMA
Market Momentum
MACD
0.09
Negative
RSI
56.36
Neutral
STOCH
63.80
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PQNT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 22.53, equal to the 50-day MA of 22.38, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.09 indicates Negative momentum. The RSI at 56.36 is Neutral, neither overbought nor oversold. The STOCH value of 63.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for PQNT.

PQNT Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$11.28M0.30%
67
Neutral
$83.95M0.55%
66
Neutral
$58.68M0.58%
62
Neutral
$26.15M0.55%
67
Neutral
$20.99M
66
Neutral
$7.83M0.65%
66
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PQNT
Pictet AI Enhanced International Equity ETF
22.82
2.69
13.36%
QUIZ
Zacks Quality International ETF
AIVI
WisdomTree International AI Enhanced Value Fund
JIDE
JPMorgan International Dynamic ETF
TACN
T. Rowe Price Active Core International Equity ETF
IVSI
Applied Finance IVS International Large ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement